CN115836082A - 包含编码特定病毒谱系抗原的核酸构建体的甲型猪流感病毒疫苗 - Google Patents

包含编码特定病毒谱系抗原的核酸构建体的甲型猪流感病毒疫苗 Download PDF

Info

Publication number
CN115836082A
CN115836082A CN202180043379.2A CN202180043379A CN115836082A CN 115836082 A CN115836082 A CN 115836082A CN 202180043379 A CN202180043379 A CN 202180043379A CN 115836082 A CN115836082 A CN 115836082A
Authority
CN
China
Prior art keywords
nucleic acid
antigen
acid sequence
lineage
iav
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180043379.2A
Other languages
English (en)
Chinese (zh)
Inventor
M·A·莫勒
B·H·纳加拉杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International BV filed Critical Intervet International BV
Publication of CN115836082A publication Critical patent/CN115836082A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08RNA viruses
    • C07K14/11Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN202180043379.2A 2020-06-19 2021-06-18 包含编码特定病毒谱系抗原的核酸构建体的甲型猪流感病毒疫苗 Pending CN115836082A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20181106 2020-06-19
EP20181106.4 2020-06-19
PCT/EP2021/066548 WO2021255221A1 (en) 2020-06-19 2021-06-18 Swine influenza a virus vaccine comprising a nucleic acid construct encoding antigens of specific virus lineages

Publications (1)

Publication Number Publication Date
CN115836082A true CN115836082A (zh) 2023-03-21

Family

ID=71111351

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180043379.2A Pending CN115836082A (zh) 2020-06-19 2021-06-18 包含编码特定病毒谱系抗原的核酸构建体的甲型猪流感病毒疫苗

Country Status (4)

Country Link
EP (1) EP4168428A1 (ja)
JP (1) JP2023530135A (ja)
CN (1) CN115836082A (ja)
WO (1) WO2021255221A1 (ja)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792462A (en) * 1995-05-23 1998-08-11 University Of North Carolina At Chapel Hill Alphavirus RNA replicon systems
US20050266550A1 (en) 2004-05-18 2005-12-01 Alphavax, Inc. TC-83-derived alphavirus vectors, particles and methods
EP2069376A4 (en) * 2006-07-21 2013-10-16 Pharmexa Inc INDUCTION OF CELLULAR IMMUNE RESPONSES TO INFLUENZA VIRUS BY COMPOSITIONS OF PEPTIDES AND NUCLEIC ACIDS
US8460913B2 (en) 2007-06-21 2013-06-11 Alpha Vax, Inc. Promoterless cassettes for expression of alpha virus structural proteins
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌(Lawsonia intracellularis)用疫苗
TWI449533B (zh) 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌(Lawsonia intracellularis)、豬肺炎黴漿菌(Mycoplasma hyopneumoniae)及豬環狀病毒(Porcine circo virus)用疫苗

Also Published As

Publication number Publication date
EP4168428A1 (en) 2023-04-26
JP2023530135A (ja) 2023-07-13
WO2021255221A1 (en) 2021-12-23

Similar Documents

Publication Publication Date Title
JP7354106B2 (ja) レプリコン粒子および油性アジュバントによるワクチン接種
JP7374893B2 (ja) ネコカリシウイルスワクチン
CN111491663B (zh) 猪甲型流感病毒疫苗
EP3880804A1 (en) Novel porcine rotavirus
CN115697398A (zh) 包含两种不同rna复制子颗粒的甲型猪流感病毒疫苗
CN115836082A (zh) 包含编码特定病毒谱系抗原的核酸构建体的甲型猪流感病毒疫苗
US20230248817A1 (en) Swine influenza a virus vaccine comprising a nucleic acid construct comprising first, second and third nucleic acid sequences encoding distinct neuraminidase antigens of the virus
CN115768472A (zh) 包含具有特定基因顺序的核酸构建体的甲型猪流感病毒疫苗
US11229699B2 (en) Feline calicivirus vaccine
RU2787596C9 (ru) Вакцина к вирусу свиного гриппа a
RU2787596C2 (ru) Вакцина к вирусу свиного гриппа a
EP3706789A1 (en) Feline calicivirus vaccine
RU2792898C2 (ru) Вакцина против кошачьего калицивируса
RU2806690C2 (ru) Вакцинация частицами репликона и масляным адъювантом
WO2023072805A1 (en) A vaccine for the protection of piglets against swine influenza a virus infection

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination